American Heart Journal
Volume 144, Issue 6 , Pages 938-940 , December 2002

Genetics in heart failure: Practical incorporation of this new biologic dimension

References 

  1. Hershberger RE, Hanson EL, Jakobs PM, et al.  A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. Am Heart J. 2002;144:1081–1086
  2. Fatkin D, MacRae C, Sasaki T, et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N Engl J Med. 1999;341:1715–1724
  3. Dries DL, Sweitzer NK, Drazner MH, et al.  Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of the left ventricular systolic dysfunction. J Am Coll Cardiol. 2001;38:421–428
  4. Trichon BH, Felker GM, Shaw LK, et al.  Mitral regurgitation as an independent risk factor for mortality in patients with heart failure and left ventricular systolic dysfunction [abstract]. J Am Coll Cardiol. 2002;39(A Suppl):194A
  5. Liggett SB, Wagoner LE, Craft LL, et al.  The Ile164 beta-2 adrenergic polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest. 1998;102:1534–1539
  6. Wagoner LE, Craft LL, Singh B, et al.  Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res. 2000;86:834–840
  7. Loh E, Rebbeck TR, Mahoney PD, et al.  Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation. 1999;99:1422–1425
  8. Herrmann S, Schmidt-Petersen K, Pfeifer J, et al.  A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 2001;22:1948–1953

☆ Reprint requests: Reprints not available from authors.

PII: S0002-8703(02)00217-X

doi: 10.1067/mhj.2002.126738

American Heart Journal
Volume 144, Issue 6 , Pages 938-940 , December 2002

Article Tools